Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Equity Ratio (2017 - 2025)

Catheter Precision has reported Equity Ratio over the past 9 years, most recently at 0.42 for Q4 2025.

  • Quarterly Equity Ratio fell 0.95% to 0.42 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42 through Dec 2025, down 0.95% year-over-year, with the annual reading at 0.42 for FY2025, 0.95% down from the prior year.
  • Equity Ratio was 0.42 for Q4 2025 at Catheter Precision, up from 0.27 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.8 in Q3 2021 and troughed at 0.26 in Q2 2025.
  • The 5-year median for Equity Ratio is 0.65 (2021), against an average of 0.58.
  • Year-over-year, Equity Ratio rose 27.19% in 2022 and then plummeted 53.01% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.65 in 2021, then fell by 15.35% to 0.55 in 2022, then increased by 25.36% to 0.69 in 2023, then crashed by 38.6% to 0.42 in 2024, then decreased by 0.95% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Equity Ratio are 0.42 (Q4 2025), 0.27 (Q3 2025), and 0.26 (Q2 2025).